Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis—a case control study

The prognosis of metastatic pancreatic ductal adenocarcinoma (PDAC) is grim, with a median overall survival of under 1 year. In our clinical practice, we observed a few cases of isolated lung metastases from PDAC with unusually long outcomes. We compared these cases in a case-control study of lung-o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Claire, Decoster, Marine, Gilabert, Aurélie, Autret, Olivier, Turrini, Sandrine, Oziel-Taieb, Flora, Poizat, Marc, Giovannini, Patrice, Viens, Juan, Iovanna, Jean-Luc, Raoul
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216749/
https://ncbi.nlm.nih.gov/pubmed/27286454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9861
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares